Alembic Pharmaceuticals reports consolidated net profit of Rs 121 crore in Q1FY24

04 Aug 2023 Evaluate

Alembic Pharmaceuticals has reported results for first quarter ended June 30, 2023 (Q1FY24). 

The company has reported net profit at Rs 97.53 crore for the quarter under review as against net loss of Rs 49.39 crore for the same quarter in the previous year. Total income of the company increased by 14.12% at Rs 1,344.12 crore for Q1FY24 as compared Rs 1,177.79 crore for the corresponding quarter previous year.  

On consolidated basis, the company has reported net profit of Rs 120.60 crore for the first quarter ended June 30, 2023 as against net loss of Rs 65.88 crore for the same quarter in the previous year. Total income of the company increased by 18.57% at Rs 1,497.81 crore for Q1FY24 as compared Rs 1,263.22 crore for the corresponding quarter previous year. 


Alembic Pharma Share Price

1041.80 3.60 (0.35%)
22-Nov-2024 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1797.80
Dr. Reddys Lab 1213.90
Cipla 1486.30
Lupin 2069.95
Zydus Lifesciences 948.70
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.